Fulgent Genetics, Inc. (FLGT)

Fulgent Genetics Revenue

Fulgent Genetics had revenue of $85.39M in the quarter ending June 30, 2026, with 4.38% growth. This brings the company's total for the last twelve months to $323.93M, up 6.83% year-over-year. In the year 2025, Fulgent Genetics had annual revenue of $322.67M with 13.83% growth. That makes Fulgent Genetics the 13,979th largest company in the world by revenue and 2,563rd in the United States.

• Revenue (ttm): $323.93M
• Revenue Growth: +6.83%
• P/S Ratio: 1.72
• Revenue / Employee: $246,336
• Employees: 1,315
• Market Cap: 556.36M

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Laboratory Services 322.22M 99.9%
• Therapeutic Development 447.00K 0.1%

By Geography

Chart

• United States 296.55M 91.9%
• Other Countries 13.21M 4.1%
• China 12.91M 4.0%

Fiscal year ended Dec 31, 2025 See the full Fulgent Genetics breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	322.67M	39.20M	13.83%
Dec 31, 2024	283.47M	-5.74M	-1.99%
Dec 31, 2023	289.21M	-329.76M	-53.27%
Dec 31, 2022	618.97M	-373.62M	-37.64%
Dec 31, 2021	992.58M	570.87M	135.37%
Dec 31, 2020	421.71M	389.18M	1,196.46%
Dec 31, 2019	32.53M	11.18M	52.35%
Dec 31, 2018	21.35M	2.62M	13.99%
Dec 31, 2017	18.73M	454.00K	2.48%
Dec 31, 2016	18.28M	8.70M	90.85%
Dec 31, 2015	9.58M	8.30M	649.30%
Dec 31, 2014	1.28M	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Jul 30, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue segment and geography data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Oct 25, 2026

Data Sources Report a data error